(Q35109031)

English

Endoglin (CD105): a target for anti-angiogenetic cancer therapy

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

title

Endoglin (CD105): a target for anti-angiogenetic cancer therapy (English)

1 reference

stated in

Europe PubMed Central

6 August 2017

1 reference

ORCID Public Data File 2021

author name string

E Fonsatti

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

12699349

retrieved

6 August 2017

M Altomonte

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

12699349

retrieved

6 August 2017

P Arslan

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

12699349

retrieved

6 August 2017

M Maio

series ordinal

4

1 reference

stated in

Europe PubMed Central

6 August 2017

1 May 2003

1 reference

stated in

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

4

1 reference

stated in

Europe PubMed Central

6 August 2017

291-296

1 reference

stated in

Europe PubMed Central

6 August 2017

4

1 reference

stated in

Europe PubMed Central

PubMed ID

12699349

retrieved

6 August 2017

Identifiers

DOI

10.2174/1389450033491073

1 reference

stated in

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

PubMed ID

12699349

retrieved

6 August 2017

(Q35109031)

Endoglin (CD105): a target for anti-angiogenetic cancer therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)